McKesson Expands its Clinical Leadership with Perinatal Acquisition

* Reuters is not responsible for the content in this press release.

Tue Apr 7, 2009 9:34am EDT

Purchase Demonstrates Commitment to Customers, Nurses and Obstetrical Care
ATLANTA--(Business Wire)--
Today, McKesson announced that it is building on the strength of its enterprise
Horizon Clinicals® solution with the acquisition of LMS Medical Systems`
intellectual property for obstetrics (OB) surveillance and archival
capabilities. Currently marketed by McKesson as Horizon Perinatal Care, the
solution integrates the fetal strip with the mother`s electronic health record
to enhance patient safety, reduce duplicate charting and leverage information
across the enterprise. Horizon Perinatal Care is the first and only OB/perinatal
information solution designed to support continuity of care between labor and
delivery and other areas in the hospital. 

"McKesson's purchase of the LMS OB surveillance and archival solution is further
proof of our strong commitment to patient safety and helping those on the front
line of care to achieve positive outcomes in obstetrics," said Merrie Wallace,
BSN, MN, national vice president, Horizon Clinicals, McKesson Provider
Technologies. "By owning the surveillance and archival solution, we`ll have the
autonomy to determine the future direction of Horizon Perinatal Care, and will
be positioned to address the needs of our customers and differentiate our
solution from both standalone niche offerings and other enterprise products." 

LMS Medical Systems, based in Montreal, Canada, is committed to ensuring a
smooth transition of all knowledge regarding the solution to McKesson for
development, support and implementations. Customers that have purchased, are
implementing or are live on Horizon Perinatal Care will experience full
continuity of service and support. They also can confidently use the solution as
part of an integrated environment that enables more collaborative and safer care
for obstetric patients. 

"Acceptance of our perinatal strategy has been strong, with more than 60
customers already live on the standalone surveillance and archival functionality
of Horizon Perinatal Care," added Wallace. "Integration with our Horizon
Clinicals solution promotes patient safety and clinical efficiency by providing
complete information and enabling the perinatal environment to benefit from
enterprise safety and quality tools. These tools include computerized provider
order entry, clinical alerting and bar-code medication administration. The
integrated solution has been live for more than a year at two healthcare
facilities representing 4,500 annual births." 

Horizon Perinatal Care also is part of McKesson`s Horizon Clinicals Care Team
Release, the first solution to unify medical and interdisciplinary care plans,
proactively driving evidence-based practice across all members of the care team.
More than two million clinicians rely on Horizon Clinicals solutions every day
to manage care complexity, increase safety and achieve measurably better
outcomes for their patients. 

About McKesson

McKesson Corporation, currently ranked 18th on the FORTUNE 500, is a healthcare
services and information technology company dedicated to helping its customers
deliver high-quality healthcare by reducing costs, streamlining processes, and
improving the quality and safety of patient care. McKesson is the
longest-operating company in healthcare today, marking its 175th anniversary
last year. Over the course of its history, McKesson has grown by providing
pharmaceutical and medical-surgical supply management across the spectrum of
care; healthcare information technology for hospitals, physicians, homecare and
payors; hospital and retail pharmacy automation; and services for manufacturers
and payors designed to improve outcomes for patients. For more information,
visit http://www.mckesson.com. 





McKesson Corporation
Yancey Casey, 404-338-2468
yancey.casey@mckesson.com



Copyright Business Wire 2009

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.